Key facts
- This page summarizes Timothy Stover's Form 3 filing for NexImmune, Inc..
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 08 Sep 2023, 19:23.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest 100% on the 18-month anniversary of November 22, 2022, subject to Mr. Stover's continued service through the applicable vesting date.
Footnote F2
25% of this option vested and became exercisable on July 6, 2022, with the remainder vesting in 36 equal monthly installments thereafter.
Footnote F3
25% of this option vested and became exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter.
Footnote F4
25% of this option will vest and become exercisable on April 4, 2024, with the remainder vesting in 36 equal monthly installments thereafter.
SEC remarks
Exhibit 24.1